2019
DOI: 10.1039/c9md00298g
|View full text |Cite
|
Sign up to set email alerts
|

Repositioning Salirasib as a new antimalarial agent

Abstract: Repurposing strategies present an enormous advantage for drug discovery, especially in malaria, where resources are scarce.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 33 publications
1
10
0
Order By: Relevance
“…Therefore, special concern should be devoted to the development of new antimicrobial agents, possessing completely different chemical structures, and working with different modes of actions. The Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction offers a versatile synthetic access to the 1,2,3-triazole heterocycle derivatives, which are associated with a wide spectrum of pharmacological activities, including antimycobacterial [18][19][20][21], antitubercular [22][23][24][25], anticancer [26][27][28][29], antiviral [30][31][32][33][34], antidiabetic [35][36][37][38], antifungal [39][40][41][42], anti-HIV [43][44][45][46], anti-inflammatory [47][48][49][50], antimalarial [51][52][53][54], anti-oxidant [55][56][57][58], anti-proliferative [59][60][61][62] properties. The 1...…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, special concern should be devoted to the development of new antimicrobial agents, possessing completely different chemical structures, and working with different modes of actions. The Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction offers a versatile synthetic access to the 1,2,3-triazole heterocycle derivatives, which are associated with a wide spectrum of pharmacological activities, including antimycobacterial [18][19][20][21], antitubercular [22][23][24][25], anticancer [26][27][28][29], antiviral [30][31][32][33][34], antidiabetic [35][36][37][38], antifungal [39][40][41][42], anti-HIV [43][44][45][46], anti-inflammatory [47][48][49][50], antimalarial [51][52][53][54], anti-oxidant [55][56][57][58], anti-proliferative [59][60][61][62] properties. The 1...…”
Section: Introductionmentioning
confidence: 99%
“…In this case, an average yield of 83% (Compounds C1 to D5, Table 1) was obtained. Our group has previously reported that geranylazide exists in solution as a mixture of inseparable regioisomers [24,25], which after the cycloaddition stage allows to generate the E and Z isomers in a 3:2 ratio [26,27]. Although in some cases it is possible to separate the E and Z triazoles obtained from this azide mixture, in this case, due to the polarity of both diasteroisomers, all attempts to obtain pure isomers by chromatographic separation were unsuccessful.…”
Section: Synthesismentioning
confidence: 99%
“…In general, statins compromised the pathogen's ability of immune evasion and survival, associated with a deficit of host-derived MVA pathway intermediates [103][104][105]. Similarly, the MEP-pathway has also been found to be an interesting drug target against Plasmodium falciparum [30,[106][107][108], Toxoplasma gondii [109], Babesia microti [110], or Mycobacterium tuberculosis [111]. Furthermore, fosmidomycin has already been evaluated in several clinical trials as a promising treatment for malaria, albeit with limited success [112].…”
Section: Infectious Diseasesmentioning
confidence: 99%